SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Unleash Jugs

JUGS is capturing community attention as a new, low-holder crypto asset that speculators believe is primed for a potential squeeze due to high concentration among top addresses. Investors are actively discussing the coin's rapid price volatility and aggressive promotional campaigns, framing it as a high-risk, high-reward play.

The Graph is an indexing protocol and global API for organizing blockchain data and making it easily accessible with GraphQL. Developers can use Graph Explorer to search, find, and publish all the public data they need to build decentralized applications. The Graph Network makes it possible to build serverless dApps that run entirely on public infrastructure.  GRT is the native token of the network that’s used to coordinate work. GRT is an ERC20 token. Node operators, called Indexers, stake and earn GRT for processing queries. Anyone can delegate GRT to Indexers to secure the network and earn rewards. Curators organize data on The Graph by signaling GRT on useful APIs, called subgraphs. Indexers, Delegators, and Curators work together to organize the data for the crypto economy and maintain a useful global API for DeFi and Web3.

The Graph

The Graph is capturing significant community attention as a fundamental infrastructure play, with investors highlighting its critical role in powering decentralized data indexing for AI agents and Web3 applications. Sentiment is heavily focused on the disconnect between the project's substantial network query growth and its current market performance, leading many to position it as a core, long-term holding within the AI and blockchain ecosystem.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

Fartcoin is seeing heightened community engagement as investors debate its role within the broader meme coin ecosystem, with many participants pointing to historical price volatility and social media hype as catalysts. Traders are actively comparing it to other speculative assets, fueling ongoing speculation about potential price movements and its overall viability as a long-term holding.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending as investors focus on its integration into the AI agentic economy and its recent transition toward a lower token inflation model. The community is actively debating the coin's potential as a long-term utility play, with many participants using market dips to accumulate positions while monitoring cross-chain interoperability developments.

GIGA is a meme token deployed on the Solana blockchain intended to honor the legend Ernest Khalimov the original “Gigachad”, by utilizing the strength of memes and “Chad” energy.  GIGA is a community run project.

GigaChad

GigaChad is capturing community attention through its long-standing cultural relevance and ongoing expansion into real-world fitness products, which investors are highlighting as a key differentiator. Enthusiastic supporters are actively discussing the project's brand longevity and potential for long-term growth as they share strategies for accumulating during market volatility.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is gaining significant market attention as its modular edge data centers provide a strategic solution to the power and latency constraints currently hampering large-scale AI infrastructure projects. The community is actively discussing the company's competitive advantage in deploying these specialized units into underserved rural markets while securing recurring revenue contracts with major industry players.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

Melania Crypto is trending as users continue to clash over the token's significant losses and the controversial nature of its association with the Trump brand. Community sentiment remains polarized, with many retail investors labeling the project a "scam" or "pump and dump" while others defend its potential as a collectible.

Bitwise Hyperliquid ETF - Bitwise Hyperliquid ETF

Bitwise Hyperliquid ETF

BHYP is generating significant buzz as investors seek direct exposure to the Hyperliquid ecosystem, with the community highlighting its utility and institutional interest. Discussions are heavily focused on the ETF's recent debut, potential buying pressure, and comparisons to early-stage opportunities in major digital assets.

Alamos Gold, Inc. is a Canadian-based intermediate gold producer. It operates through the following segments: Young-Davidson, Mulatos and Island Gold. The Young-Davidson, Mulatos and Island Gold segments represent its three operating mine sites. The company was founded on February 21, 2003 and is headquartered in Toronto, Canada.

Alamos Gold Inc. - Ordinary Shares - Class A

Alamos Gold (AGI) remains a focal point for investors as it executes a strategic acquisition of Argonaut Gold, a move designed to cement its status as a leading Canadian gold producer. The market is closely watching how the company integrates these new assets, with the community actively debating whether the recent consolidation and growth initiatives justify the current valuation against the backdrop of persistent gold demand.

Qorvo, Inc. provides semiconductor solutions for RF and power. The firm combines product and technology leadership, systems-level expertise, and global manufacturing scale to quickly solve its customers' most complex technical challenges. Qorvo serves diverse high-growth segments of large global markets, including consumer electronics, smart home/IoT, automotive, EVs, battery-powered appliances, network infrastructure, healthcare, and aerospace/defense. It operates through the following segments: High Performance Analog (HPA), Connectivity and Sensors Group (CSG), and Advanced Cellular Group (ACG). The HPA segment supplies RF and power management solutions for infrastructure, defense and aerospace, automotive power, and other markets. The CSG segment supplies connectivity and sensor components and systems featuring multiple technologies such as UWB, Matter, Bluetooth Low Energy, Zigbee, Thread, Wi-Fi, cellular IoT and MEMS-/BAW-based sensors. The ACG segment supplies cellular RF solutions for smartphones, wearables, laptops, tablets, and various other devices. The company was formed following the merger of RF Micro Devices, founded in 2015, and TriQuint Semiconductor, incorporated in 1981. It is headquartered in Greensboro, NC.

Qorvo Inc

Qorvo is seeing increased volatility and active community debate as traders monitor the stock's consolidation patterns near resistance levels. Investors are closely scrutinizing management's guidance on smartphone demand while also weighing the potential impact of long-term growth opportunities in defense, aerospace, and advanced power management technologies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Urogen Pharma (URGN) Just Flashed Golden Cross Signal: Do You Buy?

Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?

Urogen Pharma (NASDAQ:URGN) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Urogen Pharma (NASDAQ:URGN - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.47) earnings per share for the quarter, topping analysts' consensus estimates of ($0.48) by $0.01. The company had revenue of $50.96 million for the quarter, compared to analyst...

Urogen Pharma (NASDAQ:URGN) Trading Up 14% on Better-Than-Expected Earnings

Urogen Pharma (NASDAQ:URGN) Trading 14% Higher Following Better-Than-Expected Earnings...

Urogen Pharma (URGN) Reports Q1 Loss, Beats Revenue Estimates

Urogen Pharma (URGN) delivered earnings and revenue surprises of +16.44% and +16.96%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Beats Revenue Estimates

Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of +16.13% and +14.61%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Urogen Pharma (URGN) Projected to Post Quarterly Earnings on Wednesday

Urogen Pharma (NASDAQ:URGN) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-urogen-pharma-ltd-stock...

IBRX: What Anktiva's Bladder Data Says About 2026 Sales

ImmunityBio heads into 2026 riding Anktiva growth, but upcoming bladder trial data and broader use in earlier care will be key to sustaining momentum.

HC Wainwright Predicts Urogen Pharma Q1 Earnings

Urogen Pharma (NASDAQ:URGN - Free Report) - Stock analysts at HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for shares of Urogen Pharma in a report issued on Thursday, April...

Urogen Pharma (NASDAQ:URGN) Rating Increased to Strong-Buy at Jefferies Financial Group

Jefferies Financial Group raised Urogen Pharma to a "strong-buy" rating in a report on Friday...

Urogen Pharma (NASDAQ:URGN) Trading Up 9% - Should You Buy?

Urogen Pharma (NASDAQ:URGN) Trading 9% Higher - Here's Why...

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.29	--	--	N/A
Q1 '26	-$0.48	-$0.47	2.58%	BEAT
Q4 '25	-$0.50	-$0.54	-7.48%	MISSED
Q3 '25	-$0.69	-$0.69	0.34%	BEAT
Q2 '25	-$0.83	-$1.05	-25.91%	MISSED

URGN
UroGen Pharma Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Compact View

Latest URGN News

URGNUroGen Pharma Ltd